Lawrence Cheskin, MD
Director, Johns Hopkins Weight Management Center
Health, Behavior and Society, Bloomberg School of Public Health
obesity treatment, weight management, childhood obesity, gastroenterology, lifestyle and health, mHealth
Cheskin LJ, Geller G, Kahan S. Commentary: Medical ethics confronts obesity. Virtual Mentor (JAMA), April 2010, in press.
Davis LM, Michaelides M, Cheskin LJ, Moran TH, Aja S, Watkins PA, Pei Z, Contoreggi C, McCullough K, Hope B, Wang GJ, Volkow ND, Thanos PK. Bromocriptine administration reduces hyperphagia and adiposity in (fa/fa) Zucker and diet-induced obese rats and is associated with dopamine (DA) D2 receptor (D2R) and DA transporter (DAT) levels. Neuroendocrinology 89(2):152-62, 2009.
Cheskin LJ, Mitola AH, Ridoré M, Kolge S, Hwang K. Clark B. A naturalistic, controlled, crossover trial of plum juice versus psyllium versus control for improving bowel function. Internet J Nutrition Wellness 7(2), 2009.
Espeland MA, Bray GA, Neiberg R, Rejeski WJ, Knowler WC, Lang W, Cheskin LJ, Williamson D, Lewis B, Wing R. Describing patterns of weight changes using principal components analysis: Results from the Action for Health in Diabetes (Look AHEAD) research group. Ann Epidemiology 19(10):701-10, 2009.
Cheskin LJ, Margolick J, Mitola AH, Kahan S, Poddar KH, et al. Effect of nutritional supplements on immune function and body weight in malnourished adults. Nutrition Metab Insights, 2010, in press.